Nmrd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nmrd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nmrd Today - Breaking & Trending Today

Melcor Developments Ltd. Plans Quarterly Dividend of $0.11 (TSE:MRD)

Melcor Developments Ltd. (TSE:MRD – Get Free Report) declared a quarterly dividend on Tuesday, May 14th, Zacks reports. Stockholders of record on Friday, June 14th will be given a dividend of 0.11 per share on Friday, June 28th. This represents a $0.44 annualized dividend and a dividend yield of 3.77%. The ex-dividend date is Friday, […] ....

United States , Melcor Developments Company Profile , Melcor Developments Ltd , Melcor Developments , Get Free Report , Melcor Developments Daily , Tse Mrd , Real Estate ,

MRD Testing in CRC: Gaps in our Understanding and Potential Advancements

The expert panel continues the discussion with thoughts on gaps in our understanding and application of MRD testing for colorectal cancer and a look to the future, highlighting potential advancements. ....

Colorectal Cancer , Mrd Testing , Minimal Residual Disease , Circulating Tumor Dna , Patient Profile , Patient Case ,

Trajectory of CRC Treatment Landscape

The panelists provide their final thoughts, exploring the prospective treatment landscape for patients with CRC. ....

Colorectal Cancer , Mrd Testing , Minimal Residual Disease , Circulating Tumor Dna , Patient Profile , Patient Case ,

Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer: Part 2

The panel continues its review of data presented on MRD testing in colorectal cancer from the INTERCEPT and COSMOS-CRC-01 studies. ....

Colorectal Cancer , Mrd Testing , Minimal Residual Disease , Circulating Tumor Dna , Patient Profile , Patient Case ,

Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer

The panel reviews recent data on MRD testing in colorectal cancer, highlighting the INTERCEPT and COSMOS-CRC-01 studies. ....

Colorectal Cancer , Mrd Testing , Minimal Residual Disease , Circulating Tumor Dna , Patient Profile , Patient Case ,